CIK 0001563880 · Non-accelerated filer<br>Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450834299
- Phone
- 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-19 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Performance Stock Options (right to buy) | +7,500 | 37,500 | ||
| 2022-09-19 | GOOD JENNIFER L President & CEO | Grant or award · Performance Stock Options (right to buy) | +32,000 | 160,000 | ||
| 2022-07-05 | TPG GP A, LLC Former 10% Owner | Sale | −63,569 | $3.11 | $198K | 3,824,883 |
| 2022-07-01 | TPG GP A, LLC Former 10% Owner | Sale | −436,431 | $2.86 | $1.2M | 3,888,452 |
| 2022-06-30 | TPG GP A, LLC 10% owner | Sale | −429,838 | $2.77 | $1.2M | 4,324,883 |
| 2022-06-29 | TPG GP A, LLC 10% owner | Sale | −46,128 | $2.74 | $126K | 4,754,721 |
| 2022-06-29 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Performance Stock Options (right to buy) | +30,000 | 30,000 | ||
| 2022-06-29 | Forbes William P Chief Development Officer | Grant or award · Performance Stock Options (right to buy) | +48,000 | 48,000 | ||
| 2022-06-29 | GOOD JENNIFER L President & CEO | Grant or award · Performance Stock Options (right to buy) | +128,000 | 128,000 | ||
| 2022-06-23 | VANLENT ANNE Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-23 | Meeker David P Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-23 | Heffernan Michael Thomas Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-23 | Colangelo Dominick Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-23 | Cassella James V Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-23 | Mathers Edward T Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-23 | VANLENT ANNE Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-14 | GOOD JENNIFER L President & CEO | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2022-02-11 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-02-11 | Forbes William P Chief Development Officer | Grant or award · Stock Option (right to buy) | +137,500 | 137,500 |
Page 9 of 9 · 179 trades